New analyses show Novartis' EntrestoTM reduced cardiovascular death or hospitalization forheart failure, consistently benefitting patients with reduced ejection fractionregardless of prior heart failure hospital admissions or background therapy | Novartis
Entresto Full Prescribing Information, Dosage & Side Effects | MIMS Hong Kong
Entresto 97mg/103mg por.tbl.flm.56x97mg/103mg
Novartis' new heart failure medicine recommended for EU approval | Pharmafile